Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis
[Background] Systemic mastocytosis (SM) is a heterogeneous disease characterized by an expansion of KIT-mutated constitutively activated mast cells (MCs) that release MC mediators, which might act on the tumor microenvironment including other immune cells.
| Autores: | , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:dnet:digitalcsic_::8e69f0600612bb912ee83b2b4d8f4532 |
| Acceso en línea: | http://hdl.handle.net/10261/426238 https://api.elsevier.com/content/abstract/scopus_id/85209103000 |
| Access Level: | acceso abierto |
| Palabra clave: | B lymphocyte Immunoglobulin Mast cell Plasma cell Systemic mastocytosis |
| Sumario: | [Background] Systemic mastocytosis (SM) is a heterogeneous disease characterized by an expansion of KIT-mutated constitutively activated mast cells (MCs) that release MC mediators, which might act on the tumor microenvironment including other immune cells. |
|---|